Such a decrease in the potential activity of plasminogen in the last stages of BC, with an almost invariably high content of this protein in the blood plasma, may be the result of a derangement of its activation and, accordingly, a decrease in the generation of plasmin due to certain changes in the activities of proteases involved in the transformation of plasminogen during tumor progression. Here, PLG is linked to breast cancer.